FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

40062811000001103: Rinvoq 30mg modified-release tablets (AbbVie Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 29-Sep 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1925461000001116 Rinvoq 30mg modified-release tablets (AbbVie Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1925471000001114 Rinvoq 30mg modified-release tablets (AbbVie Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Rinvoq 30mg modified-release tablets (AbbVie Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Rinvoq 30mg modified-release tablets (AbbVie Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Rinvoq 30mg modified-release tablets (AbbVie Ltd) Is a Upadacitinib 30mg modified-release tablets true Inferred relationship Existential restriction modifier
Rinvoq 30mg modified-release tablets (AbbVie Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Rinvoq 30mg modified-release tablets (AbbVie Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Rinvoq 30mg modified-release tablets (AbbVie Ltd) Has specific active ingredient Upadacitinib hemihydrate true Inferred relationship Existential restriction modifier
Rinvoq 30mg modified-release tablets (AbbVie Ltd) Is a Rinvoq true Inferred relationship Existential restriction modifier
Rinvoq 30mg modified-release tablets (AbbVie Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Rinvoq 30mg modified-release tablets (AbbVie Ltd) Has specific active ingredient Upadacitinib hemihydrate false Inferred relationship Existential restriction modifier
Rinvoq 30mg modified-release tablets (AbbVie Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Rinvoq 30mg modified-release tablets (AbbVie Ltd) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Rinvoq 30mg modified-release tablets (AbbVie Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Upadacitinib false Inferred relationship Existential restriction modifier
Rinvoq 30mg modified-release tablets (AbbVie Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Rinvoq 30mg modified-release tablets (AbbVie Ltd) 28 tablet 4 x 7 tablets Has AMP True Rinvoq 30mg modified-release tablets (AbbVie Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start